What Blood Tests Monitor Lipitor?
Lipitor (atorvastatin), a statin for lowering cholesterol, requires blood tests to check efficacy and safety. The main test for efficacy is lipid panel (total cholesterol, LDL-C, HDL-C, triglycerides). Safety monitoring includes liver enzymes (ALT, AST) and creatine kinase (CK) for muscle issues.1
Ideal Lipid Levels on Lipitor
Target ranges depend on cardiovascular risk (e.g., prior heart attack, diabetes). Guidelines from American College of Cardiology/American Heart Association set these goals:
| Risk Level | LDL-C Target | Non-HDL-C Target | Triglycerides |
|------------|--------------|------------------|--------------|
| Very high (e.g., recent ACS) | <70 mg/dL | <100 mg/dL | <150 mg/dL |
| High (e.g., diabetes + risk factors) | <100 mg/dL | <130 mg/dL | <150 mg/dL |
| Moderate | <130 mg/dL (or <100 if 10-year risk >7.5%) | <160 mg/dL | <150 mg/dL |
HDL-C goal is >40 mg/dL (men) or >50 mg/dL (women). Total cholesterol <200 mg/dL is general.[2][3] Doctors adjust Lipitor dose (10-80 mg) to hit these.
Liver Enzyme Targets
ALT and AST should stay <3x upper limit of normal (ULN; typically ALT <40-50 U/L, AST <40 U/L). Mild elevations (<3x ULN) often resolve without stopping Lipitor; >3x prompts recheck or dose cut.4
CK Levels for Muscle Safety
Normal CK: 24-195 U/L (women), 24-204 U/L (men). No strict "ideal" on Lipitor, but >10x ULN signals rhabdomyolysis risk—stop drug immediately.5
When and How Often to Test
Baseline before starting, then 4-12 weeks after initiation or dose change, every 3-12 months if stable. High-risk patients test liver enzymes more often.2
Factors Affecting Targets
Age, kidney function, other drugs (e.g., fibrates raise myopathy risk), and genetics influence ranges. Consult doctor for personalized goals—self-monitoring misses context like ASCVD risk calculators.3